Showing results (111-120 of 332) with videos related to
Sort By:
Pageof 34
Expert Review of Anticancer Therapy|May 19, 2009
Treatment options for recurrent glioblastoma: pitfalls and future trendsEnrico Franceschi, Alicia Tosoni, Stefania Bartolini, et al.Expert Opinion on Drug Discovery|June 2, 2012
Advances in malignant glioma drug discoveryDavid A Reardon, James R Perry, Alba A Brandes, et al.Zeitschrift Fur Kardiologie|February 1, 1997
[Atrial sensing and atrioventricular synchrony in single lead VDD pacemakers. Can the appearance of atrial undersensing be predicted?]U K Wiegand, R Schneider, F Bode, et al.Critical Reviews in Oncology/Hematology|April 9, 2008
Glioblastoma in adultsAlba A Brandes, Alicia Tosoni, Enrico Franceschi, et al.Anticancer Research|October 30, 2004
Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancerFranco Lumachi, Stefano M M Basso, Alba A Brandes, et al.Anticancer Research|March 26, 2002
Predictive value of different prognostic factors in breast cancer recurrences: multivariate analysis using a logistic regression modelF Lumachi, M Ermani, A A Brandes, et al.Blood|December 14, 2002
UbcH5A, a member of human E2 ubiquitin-conjugating enzymes, is closely related to SFT, a stimulator of iron transport, and is up-regulated in hereditary hemochromatosisSven G Gehrke, Hans-Dieter Riedel, Thomas Herrmann, et al.Blood|March 15, 2003
Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound ironSven G Gehrke, Hasan Kulaksiz, Thomas Herrmann, et al.Zeitschrift Fur Kardiologie|May 1, 1994
[The reliability of computer-assisted long-term ECG analysis of pacemaker malfunction in patients with ventricular demand pacemakers]A Brandes, B D Gonska, W K Distler, et al.Future Oncology (London, England)|July 24, 2014
Resistance to antiangiogenic therapiesMarco Bartolotti, Enrico Franceschi, Rosalba Poggi, et al.Pageof 34